Department of Oral Biology, New Jersey Dental School, University of Medicine and Dentistry of New Jersey, Newark, NJ 071003, USA.
Arch Oral Biol. 2013 Jun;58(6):611-20. doi: 10.1016/j.archoralbio.2012.10.009. Epub 2012 Dec 6.
While Aggregatibacter actinomycetemcomitans (Aa) is highly associated with localised aggressive periodontitis (LAP) many Aa-carriers do not develop LAP. This study was designed to determine whether specific salivary factors could distinguish between subjects who have Aa initially and remain healthy (H/AA) as compared to those who develop LAP (LAP/AA).
H/AA subjects and healthy controls with no Aa (H) were enrolled in a longitudinal cohort study to investigate initiation of bone loss (LAP) over 3 years. After detection of LAP, stored saliva from 10 H, 10 H/AA, and 10 LAP/AA subjects was thawed, processed, and tested for (1) lactoferrin (Lf) concentration and iron levels; (2) agglutination of Aa; (3) killing of Gram-positive bacteria.
LAP/AA saliva levels of Lf iron were low prior to and after bone loss (3.6+1.7ngFe/μg) (LAP/AA vs. H and H/AA p≤0.01). Saliva from H/AA subjects caused Aa to agglutinate significantly more than H or LAP/AA saliva (p≤0.01). LAP/AA saliva killed Streptococcus mutans, Streptococcus sanguis and Lactobacillus in vitro by >83%. Saliva from H individuals killed these bacteria by <3.3% (LAP/AA vs. H; p≤0.01). H/AA killing was intermediate.
LAP/AA saliva showed: low levels of Lf iron, minimal Aa agglutinating activity, and high killing activity against Gram-positive bacteria. Aa-positive healthy saliva (H/AA) showed: higher levels of Lf iron, maximal Aa agglutinating activity, and moderate killing of Gram-positive bacteria. A salivary activity profile can distinguish between subjects who are Aa-positive and remain healthy from those who develop LAP.
虽然伴放线放线杆菌(Aa)与局限性侵袭性牙周炎(LAP)高度相关,但许多 Aa 携带者并未发展为 LAP。本研究旨在确定特定的唾液因素是否可以区分最初携带 Aa 且保持健康的受试者(H/AA)与发展为 LAP 的受试者(LAP/AA)。
H/AA 受试者和无 Aa 的健康对照者(H)被纳入一项纵向队列研究,以调查 3 年内骨丢失(LAP)的起始情况。在检测到 LAP 后,解冻来自 10 名 H、10 名 H/AA 和 10 名 LAP/AA 受试者的储存唾液,进行处理,并检测(1)乳铁蛋白(Lf)浓度和铁水平;(2)Aa 的凝集;(3)革兰阳性菌的杀伤。
在发生骨丢失之前和之后,LAP/AA 唾液中的 Lf 铁水平较低(3.6+1.7ngFe/μg)(LAP/AA 与 H 和 H/AA 相比,p≤0.01)。H/AA 受试者的唾液使 Aa 凝集的程度明显高于 H 或 LAP/AA 唾液(p≤0.01)。LAP/AA 唾液在体外可杀死>83%的变形链球菌、血链球菌和乳杆菌。来自 H 个体的唾液可杀死这些细菌的<3.3%(LAP/AA 与 H;p≤0.01)。H/AA 的杀伤作用介于两者之间。
LAP/AA 唾液表现出:Lf 铁水平低、Aa 凝集活性低、对革兰阳性菌的杀伤活性高。Aa 阳性健康唾液(H/AA)表现出:Lf 铁水平较高、Aa 凝集活性最大、对革兰阳性菌的杀伤能力中等。唾液活性谱可区分 Aa 阳性且保持健康的受试者与发展为 LAP 的受试者。